NewsModerna Announced They Begin Clinical Trials On Booster Dose Of Vaccine Against Omicron
The Moderna pharmaceutical company announced that it begin clinical trials in the second phase of its study of a booster dose of its specific vaccine to combat the omicron variant of COVID-19. In a statement, Moderna announced they begin clinical trials of the vaccine. They explained that the second phase...